Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2010
|
| gptkbp:ATCCode |
A16AB10
|
| gptkbp:CASNumber |
880773-53-7
|
| gptkbp:firstApprovalRegion |
gptkb:European_Union
gptkb:United_States |
| gptkbp:form |
solution for infusion
|
| gptkbp:genericName |
velaglucerase alfa
|
| https://www.w3.org/2000/01/rdf-schema#label |
VPRIV
|
| gptkbp:indication |
treatment of type 1 Gaucher disease
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Takeda_Pharmaceutical_Company
|
| gptkbp:mechanismOfAction |
enzyme replacement therapy
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:product |
recombinant human glucocerebrosidase
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:RxNorm |
1114382
|
| gptkbp:sideEffect |
nausea
fatigue headache back pain joint pain infusion-related reaction |
| gptkbp:storage |
2°C to 8°C
|
| gptkbp:UNII |
6U8Z86QW8E
|
| gptkbp:usedFor |
gptkb:Gaucher_disease_type_1
|
| gptkbp:bfsParent |
gptkb:Cerezyme
|
| gptkbp:bfsLayer |
7
|